Ketamin / KAPGeprüft — Website des AnbietersPrivatmarkt-Modell

Ordination Dr. Buchmayer

Wien, Österreich

Behandlung & Zugang

  • Angebotene BehandlungenDepression (including treatment-resistant depression) · Esketamine therapy (Spravato nasal spray and infusion) · TMS / iTBS · tDCS (medication-free depression treatment) · Psychotherapy · Pharmacogenetic medication optimisation · ADHD · Dementia · Burnout · Cannabis/dronabinol treatment · Addiction (alcohol, nicotine) · Driving-licence (traffic-medicine) assessments and expert reports · Telemedicine follow-up · Inpatient treatment arrangement in Viennese private clinics
  • ZugangswegPrivat / Selbstzahler
  • Preise (vom Anbieter veröffentlicht)First consultation EUR 400 (40 min; new price from 01.03.2026, previously EUR 330); esketamine/Spravato session EUR 150-250 (120 min); esketamine continuation intake EUR 200; rTMS/iTBS from EUR 120 per session; tDCS from EUR 22.50 per treatment; follow-up consultation EUR 160 - per the practice's fee overview (updated 01/2026) — wie veröffentlicht, geprüft am 2026-07-27
  • Telefon+43 664 4628495
  • Websitehttps://dr.buchmayer.eu

Über diesen Anbieter

Details auf Englisch.

Dr. Florian Buchmayer is a psychiatrist and specialist in psychotherapeutic medicine running a private (Wahlarzt) practice in the LEBEN PSYCHE Zentrum at Garnisongasse 7, 1090 Vienna. His focus is depression, particularly treatment-resistant depression, treated with esketamine - both Spravato nasal spray and infusion, administered in the practice - alongside TMS/iTBS, medication-free tDCS, pharmacogenetics and psychotherapy; ADHD, dementia and traffic-medicine assessments are further areas. Esketamine induction comprises eight sessions within four weeks with evaluation in week four, followed by maintenance of two to four sessions per four weeks; total treatment usually lasts at least six to nine months. Appointments can be booked online, telemedicine follow-up is offered, and inpatient treatment can be arranged in Viennese private clinics.

Leistungen & Programme

Details auf Englisch.

  • First consultation (general or depression-focused)40-minute initial assessment; for depression an extended consultation covering diagnosis confirmation and therapy options (tDCS, esketamine, TMS). EUR 400 (from 01.03.2026; EUR 330 before)
  • Esketamine/Spravato treatment120-minute supervised session for treatment-resistant depression; intranasal Spravato or infusion, both offered in the practice. Continuation of hospital-initiated Spravato treatment is possible. EUR 150-250 per session; continuation intake consultation EUR 200
  • TMS / iTBSMagnetic brain stimulation for depression (1x rTMS or 2x iTBS per sitting). From EUR 120 per session
  • tDCSMedication-free transcranial direct-current stimulation for depression, including fibromyalgia/pain applications. From EUR 22.50 per treatment
  • Follow-up consultation20-minute review appointment; telemedicine via secure video also available with e-prescriptions to the eCard. EUR 160
  • Assessments and reportsTraffic-medicine (driving-licence) examination EUR 400; expert reports from EUR 600; written specialist report EUR 50 per report. EUR 50-600+

Programme & Studien

ProgrammArtStatus
Esketamine induction phase
8 treatments within 4 weeks; treatment success usually appears by week 4, when evaluation and next steps are agreed.
treatment protocoloffered
Esketamine maintenance phase
2-4 treatments per 4 weeks; total duration with positive response at least 6-9 months. Takeover of ongoing Spravato treatments is offered.
treatment protocoloffered
Telemedicine
Continued psychiatric treatment via secure video; costs currently reimbursed by insurers as usual, per the practice.
remote careoffered
Inpatient treatment
Admission can be arranged in several Viennese private clinics, e.g., for severe depressive or anxiety states.
hospital arrangementoffered

Preise

Details auf Englisch.

LeistungPreis
First consultation (general or depression, 40 min)
From 01.03.2026; EUR 330 valid from 01.03.2025
EUR 400
Follow-up consultation (20 min)EUR 160
Esketamine/Spravato session (120 min)
For treatment-resistant depression
EUR 150-250
Esketamine continuation intake (20 min)
Therapy takeover
EUR 200
tDCS treatment (30 min)From EUR 22.50
1x rTMS / 2x iTBS session (30-60 min)From EUR 120
Traffic-medicine examination (20 min)
Pure private service, not reimbursed
EUR 400
Expert report (60+ min)
Preliminary discussion recommended
From EUR 600
Written specialist report (Befund)
Charged per report in addition to treatment fees
EUR 50

Die Preise stammen von der Website des Anbieters und wurden zuletzt geprüft am . Bestätigen Sie den aktuellen Preis vor der Buchung immer direkt beim Anbieter.

Ausstattung & Sprachen

Details auf Englisch.

  • Ausstattung
    • Practice in the LEBEN PSYCHE Zentrum, Garnisongasse 7/27, 1090 Vienna (staircase 2, 3rd floor)
    • Online booking via Latido; e-prescription to eCard; secure telemedicine video service
    • Opening hours Mon/Tue/Thu 12-19, Wed 14-18, Fri 10-18; appointments by arrangement
  • SprachenWebsite and practice communication in German.
  • TeamPrimarius a.D. Dr. med. Florian Buchmayer, specialist in psychiatry and psychotherapeutic medicine, practising within the LEBEN PSYCHE Zentrum with reception assistants. The practice reports patient-survey overall satisfaction of 9.2/10 for its esketamine treatment (anonymised questionnaire, 02/2025).

Häufige Fragen

Details auf Englisch.

What does esketamine treatment cost and what is included?

A depression first consultation costs EUR 400 (40 min) covering diagnosis confirmation and therapy education; each supervised esketamine/Spravato session (120 min) costs EUR 150-250. The practice notes the overall costs of esketamine treatment are generally manageable and offers advance advice. Written reports are EUR 50 each in addition.

How does reimbursement work as a Wahlarzt patient?

The practice has no direct billing contract with public insurers: you pay on site (cash, debit or credit card) and can submit the invoice to your insurer for partial reimbursement at the insurer's rates. For OGK, SVS and BVAEB patients the practice can submit electronically (WAHonline). Supplementary private insurance with a private-doctor option usually covers most or all remaining costs. Because Spravato is expensive, a prescription approval is usually required - the practice handles the indication and application. Telemedicine costs are currently reimbursed as usual.

How do I start?

Book online via the Latido booking page (choose first examination for new patients), or contact the practice by phone (+43 664 4628495, weekdays from 12:00), email, SMS or messenger. From 01.07.2026 Austrian law requires presenting your eCard in person at the terminal (exceptions: telemedicine, purely private/foreign insurance). Cancellations should be made 48 hours ahead.

How does the esketamine protocol run?

Induction is 8 treatments within 4 weeks, with evaluation in week 4; maintenance is 2-4 treatments per 4 weeks; total duration with positive response is at least 6-9 months. Single sessions last about 1.5-2 hours. Do not eat for 2 hours or drink for 30 minutes beforehand; do not drive afterwards - the practice advises arranging a pick-up. A companion may join, and patients already stabilised on Spravato in hospital can transfer without necessarily needing a new first examination.

What if I do not want medication?

The practice offers non-drug biological options for depression - tDCS (from EUR 22.50 per treatment) and TMS/iTBS (from EUR 120 per session) - as well as psychotherapy, presented as real options for people who do not wish to take medication or have not responded to it.

Alternativen im Blick? In Austria, esketamine (Spravato) is also initiated and administered in hospital psychiatric settings, and inpatient treatment in public or private psychiatric departments is an established route for severe depression alongside office-based private care.

Verifizierung

Die Angaben wurden manuell gegen die vom Anbieter selbst veröffentlichten Informationen geprüft; siehe das Datum der letzten Verifizierung an diesem Eintrag.

  • Lizenz / RegisterÖffentliches Studienregister (ClinicalTrials.gov / EU CTIS)
  • Quellehttps://dr.buchmayer.eu
  • Zuletzt verifiziert

Einen Fehler entdeckt? Siehe unsere Methodik (auf Englisch) — dort steht, wie Einträge geprüft werden und wie Sie eine Korrektur melden.